2016年02月18日 星期四 23:57:08

掌握大中華市場脈動.亞洲專業華文生技產業月刊

Loading 活動

« All 活動

  • This event has passed.

第三屆BioCentury China Healthcare Summit年會

2016-10-18 08:00:00 - 2016-10-19 17:30:00

USD$999
Register Now for The BioCentury China Healthcare Summit: The Bridge to Innovation
 
The BioCentury China Healthcare Summit: The Bridge to Innovation
   Organized by BioCentury and BayHelix in collaboration with McKinsey & Co.

本屆年會只限高層管理者、科學專家及投資者參加,名額有限。

頂尖掌門人和研發總裁們將在上海引領頭腦風暴

第三屆BioCentury China Healthcare Summit年會將於1018日至19日在上海舉行。

此屆峰會將著重於為當下中國生物醫藥和醫療技術的研發者們答疑解惑。伴隨著中國不斷提高在全球醫療市場中的創新目標,醫療健康行業的高層管理者們將為本土和跨國公司構建衡量基準。 

 二天的日程精彩紛呈,多名行業內和學術界的關鍵意見領袖,以及資深投資者們將齊聚一堂,進行戰略討論和總結。作為今年會議眾多亮點之一,由中國掌門人和本土研發總裁們出席的,關於企業發展和研發的路演環節,將是您不容錯過的寶貴機會! 

 環球生技月刊為本次活動合作媒體。


 

Meeting of the Minds in Innovation
Register Today

The 3rd annual BioCentury China Healthcare Summit has assembled a critical mass of leaders who will help China “Cross the Bridge to Innovation.”

More Than 80 Experts & Key Opinion Leaders

More than 80 experts and key opinion leaders from China and abroad are set to descend on Shanghai October 18-19. With them, they will bring deep knowledge and insight on the next steps required for creating a modern healthcare ecosystem in China based on a foundation of scientific, business and policy innovation.

This renowned roster of speakers and panelists include research pathfinders from academia; heads of research from leading Chinese pharmas; general managers from biopharmas and medtechs; and top venture capital and healthcare investors.

 

View SpeakersRegister Now


Networking & Special Events

Over two productive days, the BioCentury China Healthcare Summit offers the single most efficient way to network with your colleagues on the front lines of healthcare innovation.

The Gala Opening Reception on Monday evening, October 17, hosted by BioCentury, Bristol-Myers Squibb and OrbiMed, provides the first such opportunity to network with your VIP colleagues. The following night (Tuesday, October 18), the Gala Reception and Networking Dinner, hosted by I-Bridge Capital, C-Bridge Capital Partners and BioCentury presents yet another opportunity to share perspectives with your peers. Also on Tuesday is a celebration of the 7th Annual BayHelix Awards for outstanding contributions to China’s innovation ecosystem.

Seating is limited and filling quickly, so register today to reserve your seat.


 
Register HereView the Agenda


BioCentury China Healthcare Summit Speakers

Jun BAO, Ph.D.
SVP & Chief Business Officer
Shenogen Pharma Group Ltd.
En LI, Ph.D.
Head, China
Novartis Institutes for BioMedical Research 

Joshua Berlin
Executive Director, New Ventures
BioCentury

Stanley Li, M.D.
Founder
DXY
Karen Bernstein, Ph.D.
Chairman
BioCentury
Karl Lintel
General Manager & President, China
Bristol-Myers Squibb Co.
Friedhelm Blobel, Ph.D.
CEO
SciClone Pharmaceuticals Inc.
Lei LIU, Ph.D.
Professor
Fudan University
John Cai, Ph.D.
Director, Center for Healthcare Management and Policy, China Europe International Business School
Scott Liu, Ph.D.
President & CEO
Shanghai Henlius Biotech Co. Ltd.
Guoqing CAO, Ph.D.
VP
Jiangsu Hengrui Medicine Co.
Thomas Mickelson
Chief Marketing Officer, China
Eli Lilly and Co.
William Cao, Ph.D.
President & CEO
Yikon Genomics Co. Ltd.
Hua MU, M.D., Ph.D.
Chief Scientific Officer & President of R&D
Simcere Pharmaceutical Group
Yanan CAO, M.D.
Associate Research Fellow, Ruijin Hospital, Shanghai Jiao Tong University
Satoru Noguchi
Vice President of Emerging Market Business Unit, Area Head of Greater China, Chairman of Takeda (China) Holdings
Takeda Pharmaceutical Company Limited
CHEN Lijuan, Ph.D.
Deputy Director, State Key Laboratory of Biotherapy, Sichuan University
Alexander Ng
Deputy Director, China Program
Bill & Melinda Gates Foundation
Jing Cheng, Ph.D.
CEO, CapitalBio and Cheung Kong
Professor, Tsinghua University
Christopher Round
President
MSD China
Lifei CHENG, Ph.D.
VP, Strategy, Business Development & Ventures, Medtronic plc
Victor Shi, Ph.D.
Founding President, Asia Pacific
Qiagen

Hong CHOW
General Manager, China
Shanghai Roche Pharmaceuticals Ltd.

SONG Ruilin
Executive President
PhIRDA (China Pharmaceutical Innovation and Research Development Association)
Carl Decicco, Ph.D.
Head of Discovery
Bristol-Myers Squibb Co.
Weiguo SU, Ph.D.
EVP & CSO
Hutchison MediPharma Holdings Ltd. 

James Deng, M.D.
SVP & General Manager, Greater China
Becton Dickinson and Co.

Hongye SUN, Ph.D.
Chief Technology Officer
WuXi NextCode
Mike Dethick
Managing Director
RDPAC (R&D-based Pharmaceutical Association Committee)
TAN Bo
CFO & EVP
3SBio Inc.
Richard Ding
Corporate VP & Head, Asia-Pacific Region
bioMerieux S.A.

Martin Tolar, M.D., Ph.D.
Founder, President & CEO
Alzheon Inc.

DONG Chen, Ph.D.
Professor and Director, Institute for Immunology and Executive Dean, School of Medicine, Tsinghua University
Jiabing WANG, Ph.D.
VP & Head of R&D Centers
Betta Pharmaceuticals Co. Ltd.
Jie D’elia, Ph.D.
Executive Director, Business Development Transactions
Bristol-Myers Squibb
WANG Jie, M.D., Ph.D.
Co-founder & CEO, SyMap Medical (Suzhou) Ltd. and VP & Professor, Jiangsu Academy of Clinical and Translational Research,
Jiangsu Province Hospital
Stephen Doyle
VP & Head, Specialty Care, China, Boehringer Ingelheim GmbH
Jonathan Wang, Ph.D.
Co-founder & Senior Managing Director
OrbiMed Asia

Samantha Du, Ph.D.
Founder, Chairman & CEO
Zai Lab Ltd.

Yi WANG, M.D., Ph.D.
VP, Children’s Hospital
Fudan University 

Simone Fishburn, Ph.D.
Editor, BioCentury Innovations
BioCentury

WANG Jun, Ph.D.
Founder & CEO
iCarbonX
David Flores
President & CEO
BioCentury
Jimmy Wei, Ph.D.
Managing Partner
I-Bridge Capital
FU Daxu, Ph.D.
Party Secretary, CPC & Deputy Director, Shanghai Center of Biomedicine Development
Peter Wirth
Chairman, FORMA Therapeutics Holdings LLC & Senior Advisor, Zai Lab Ltd.
GAO Chengyu
Manager, Regulatory Strategy, Global Essential Health, Pfizer Inc.
Ian Wisenberg
CFO
BioDuro, LLC
Brian Gu, Ph.D.
Managing Director & Co-head Asia Pacific M&A, TMT, Healthcare & Sponsors, JP Morgan
WU Bo
VP
Tencent Holdings Ltd.
Dahai Guo
CEO
PuraCap Pharmaceutical LLC
XIAO Lei, Ph.D.
Founder, President & CSO
Innovative Cellular Therapeutics Co. Ltd.
Ruth Herzog, Ph.D.
Head, Office of Technology Transfer
German Cancer Research Center, Heidelberg
XU Ming, Ph.D.
VP
CCCMHPIE (China Chamber of Commerce for Import & Export of Medicines & Health Products)
Regina Hodits, Ph.D.
General Partner
Wellington Partners
Chen Yang
Head of China Life Sciences Practice
Sidley Austin LLP
Zhi HONG, Ph.D.
SVP & Head of Infectious Diseases R&D
GlaxoSmithKline PLC
Steve Yang, Ph.D.
EVP & COO
WuXi AppTec
Edward Hu
CFO & Chief Investment Officer
WuXi Apptec
Xiang S YE, Ph.D.
Senior Director, Cancer Research China/Asia
Eli Lilly and Co. 

James Huang
Managing Partner
KPCB China

George Yeh
President
Taiwan Liposome Co. Ltd.
HUANG Shiang, M.D.
Founder & CEO
Wuhan Kindstar Diagnostics Co. Ltd. 
Richard Yeh
Managing Director, Global Investment Research, Asia Pacific, Goldman Sachs (Asia) LLC
Mathias Hukkelhoven, Ph.D.
Senior Vice President, Global Regulatory, Safety & Biometrics
Bristol-Myers Squibb
Debra Yu, M.D.
Managing Director & Head of Cross-Border Healthcare Investment Banking
China Renaissance Securities
Darren Ji, Ph.D.
VP & Global Head, Asia and Emerging Markets Partnering
Roche
Frank Yu
Founder & CEO
Ally Bridge Group
Meng JIANG
Partner
C-Bridge Capital Partners LLC
Dan Zhang, M.D.
Chairman
Fountain Medical Development Ltd.
Sammy Hua JIANG
Vice President
Luye Pharma Group
Jimmy Zhang, Ph.D. MBA
Managing Director, Cross-Border Investment, CL Investment Group
Kewen JIN, M.D.
Chairman, BayHelix &
Managing Partner, Serica Capital
Linqi ZHANG, Ph.D.
Professor & Director, Comprehensive AIDS Research Center, Center for Global Health and Infectious Diseases, School of Medicine, Tsinghua University
BAO Jun, Ph.D.
Senior Vice President and Chief Business Officer
Shenogen Pharma Group
ZHANG Wei, Ph.D., M.D.
Professor, Guanghua School of Management
Peking University
Franck Le Deu
Senior Partner & Head of
Greater China Healthcare Practice
McKinsey & Co.
Ling Zhen
SVP & General Manager, China
Quintiles
Daniel Lee, Ph.D.
Head, BioMedical Technology Cluster
Hong Kong Science & Technology Parks Corp.
ZHENG Limou, Ph.D.
CEO
Amoy Diagnostics Co. Ltd. 
Nisa Leung
Managing Partner
Qiming Venture Partners
Gaobo ZHOU
Partner
McKinsey & Co.
Benjamin LI, Ph.D.
CEO
Lee’s Pharmaceutical Holdings Ltd.
ZHU Zhengying, M.D., Ph.D.
Deputy General Manager and Chief Medical Officer
Shandong Luoxin Pharmaceutical Group Stock Co. Ltd.
Bin LI, Ph.D.
CEO
Ally Bridge LB Healthcare Fund
Gordon (Gang) Zong
CEO
Sinoipro IP Management and Technology Transfer Co. Ltd.

 

 
       

       
Insights Partner
McKinsey & Company
       
Science & Innovation Showcase Partners
Kleiner Perkins Caufield & Byers ChinaKleiner Perkins Caufield & Byers China
       
Sponsors
Ally Bridge GroupBioDuro
Bristol-Myers SquibbCBridge Capital
CelgeneDXY
Fountain Medical Development Ltd.IBridge Capital
ICVLee's Pharmaceutical
Shandong Luoxin Pharmaceutical GroupOrbiMed
PfizerQiming Venture Partners
QuintilesRoche
SciClone Pharmaceuticalstlc
Zai Lab 
       
Supporting Organizations
PhIRDARDPAC
BFC GroupLingMed
GBILingMed
Lychee GroupPharmaDJ
     
 

 

明細:

開始:
2016-10-18 08:00:00
結束:
2016-10-19 17:30:00
費用:
USD$999
活動 Category:
活動 Tags:

主辦人

BioCentury
BayHelix Group(百華協會)

地點

上海金茂君悦大酒店
浦东新区世纪大道 88 号金茂大厦
上海, 中國
+ Google 地圖
網址:
http://shanghai.grand.hyatt.com/

Copyright© 2019 環球生技投資股份有限公司. All rights reserved.

讀者服務電話:(02)2726-1065  時間:週一 ~ 週五 9:00 ~ 18:00

服務信箱:service@gbimonthly.com

地址:110臺北市信義區松德路161號2樓之3, Taiwan